Radiopharmacy2

[WP-32-5] LC-MS/MS identification and assessment of quantitative structure–activity relationship for trace chemical impurities contained in the therapeutic formulation of 64Cu-ATSM

Chika Igarashi^1,2、Hiroki Matsumoto^1,2、Masashi Takahashi^1,3、Fukiko Hihara¹、Tomoko Tachibana¹、Ming-Rong Zhang¹、Hiroaki Kurihara²、Tatsuya Higashi¹、Yukie Yoshii^1,2 (1.Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology、2.Department of Diagnostic Radiology, Kanagawa Cancer Center、3.Faculty of Science, Toho University)